© 2026 Scopeora News & Life
Vijay Pande launches VZVC with a lean, AI-native strategy, focusing on precision medicine, clinical trials, and fewer biotech investments.
We use cookies to improve your experience and analyze site traffic. Privacy Policy
Required for the site to function properly. These cookies cannot be disabled.
Help us understand how visitors use our site to improve your experience. (Google Analytics)